Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
DRUG:
farletuzumab ecteribulin (MORAb-202)
i
Other names:
MORAb-202, MORAb 202, MORAB-202
Associations
(4)
News
Trials
Company:
BMS, Eisai
Associations
(4)
News
Trials
C3 | Sensitive
D | Sensitive
C3 | Resistant
D | Resistant
Show legend
Group by Gene:
Include preclinical:
Endometrial Cancer
Ovarian Cancer
Solid Tumor
FOLR1 expression
D
FOLR1 expression
|
Endometrial Cancer
|
MORAb-202
[
D
]
C3
FOLR1 expression
|
Solid Tumor
|
MORAb-202
[
C3
]
FOSL1 expression
D
FOSL1 expression
|
Ovarian Cancer
|
MORAb-202
[
D
]
MSLN expression
D
MSLN expression
|
Ovarian Cancer
|
MORAb-202
[
D
]
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login